News + Filings Transactions Holdings
All 13F 13D/G Other
|
Polaris Venture Management Co. V, L.L.C.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/18/2019 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on Phreesia, Inc.
Txns:
| Sold 344,599 shares
@ $24.479, valued at
$8.4M
Sold 6,716 shares
@ $24.479, valued at
$164.4k
Sold 2,360 shares
@ $24.479, valued at
$57.8k
Sold 3,446 shares
@ $24.479, valued at
$84.4k
|
|
07/24/2019 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on Phreesia, Inc.
Txns:
| Converted 3,828,872 shares
@ $0 Converted 74,624 shares
@ $0 Converted 26,227 shares
@ $0 Converted 38,289 shares
@ $0 Sold 382,887 shares
@ $18, valued at
$6.9M
Sold 7,462 shares
@ $18, valued at
$134.3k
Sold 2,622 shares
@ $18, valued at
$47.2k
Sold 3,828 shares
@ $18, valued at
$68.9k
Converted 8,413,256 options to buy
@ $0 Converted 163,973 options to buy
@ $0 Converted 57,631 options to buy
@ $0 |
|
07/17/2019 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on Cardlytics, Inc.
Txns:
| Sold 19,283 shares
@ $27.7259, valued at
$534.6k
Sold 20,227 shares
@ $27.8689, valued at
$563.7k
Sold 26,778 shares
@ $27.447, valued at
$735k
Sold 376 shares
@ $27.7259, valued at
$10.4k
Sold 394 shares
@ $27.8689, valued at
$11k
Sold 552 shares
@ $27.447, valued at
$15.2k
Sold 132 shares
@ $27.7259, valued at
$3.7k
Sold 139 shares
@ $27.8689, valued at
$3.9k
Sold 183 shares
@ $27.447, valued at
$5k
Sold 193 shares
@ $27.7259, valued at
$5.4k
Sold 202 shares
@ $27.8689, valued at
$5.6k
|
|
06/11/2019 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on Cardlytics, Inc.
Txns:
| Sold 96,493 shares
@ $25.6212, valued at
$2.5M
Sold 1,881 shares
@ $25.6212, valued at
$48.2k
Sold 661 shares
@ $25.6212, valued at
$16.9k
Sold 965 shares
@ $25.6212, valued at
$24.7k
|
|
06/06/2019 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on Cardlytics, Inc.
Txns:
| Sold 35,103 shares
@ $23.2817, valued at
$817.3k
Sold 3,939 shares
@ $23.6252, valued at
$93.1k
Sold 32,294 shares
@ $24.993, valued at
$807.1k
Sold 1,036 shares
@ $25.3025, valued at
$26.2k
Sold 294 shares
@ $25, valued at
$7.4k
Sold 684 shares
@ $23.2817, valued at
$15.9k
Sold 80 shares
@ $23.6333, valued at
$1.9k
Sold 604 shares
@ $24.9882, valued at
$15.1k
Sold 42 shares
@ $25.3017, valued at
$1.1k
Sold 6 shares
@ $25, valued at
$150 Sold 240 shares
@ $23.2817, valued at
$5.6k
|
|
05/30/2019 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on Cardlytics, Inc.
Txns:
| Sold 96,493 shares
@ $23.0381, valued at
$2.2M
Sold 1,881 shares
@ $23.0381, valued at
$43.3k
Sold 661 shares
@ $23.0381, valued at
$15.2k
Sold 965 shares
@ $23.0381, valued at
$22.2k
|
|
09/14/2018 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on Cardlytics, Inc.
Txns:
| Sold 75,805 shares
@ $24.67, valued at
$1.9M
Sold 20,688 shares
@ $25.188, valued at
$521.1k
Sold 45,743 shares
@ $25.517, valued at
$1.2M
Sold 2,504 shares
@ $26.413, valued at
$66.1k
Sold 1,477 shares
@ $24.669, valued at
$36.4k
Sold 404 shares
@ $25.188, valued at
$10.2k
Sold 891 shares
@ $25.517, valued at
$22.7k
Sold 49 shares
@ $26.413, valued at
$1.3k
Sold 518 shares
@ $24.669, valued at
$12.8k
Sold 143 shares
@ $25.187, valued at
$3.6k
Sold 314 shares
@ $25.517, valued at
$8k
|
|
08/09/2018 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on Cardlytics, Inc.
Txns:
| Granted 64,038 warrants
@ $0.0004, valued at
$25.6 Granted 1,247 warrants
@ $0.0004, valued at
$0.5 Granted 438 warrants
@ $0.0004, valued at
$0.2 Granted 641 warrants
@ $0.0004, valued at
$0.3 Exercised 64,038 warrants
@ $0.0004, valued at
$25.6 Exercised 1,247 warrants
@ $0.0004, valued at
$0.5 Exercised 438 warrants
@ $0.0004, valued at
$0.2 Exercised 641 warrants
@ $0.0004, valued at
$0.3 |
|
04/05/2018 |
4
| MCGUIRE TERRANCE (10% Owner) has filed a Form 4 on Pulmatrix, Inc.
Txns:
| Bought 345,551 shares
@ $0 Bought 6,478 shares
@ $0 Bought 769,989 shares
@ $0 Bought 15,007 shares
@ $0 Bought 5,275 shares
@ $0 Bought 7,700 shares
@ $0 Bought 345,551 options to buy
@ $0.65, valued at
$224.6k
Bought 345,551 options to buy
@ $0.75, valued at
$259.2k
Bought 6,478 options to buy
@ $0.65, valued at
$4.2k
Bought 6,478 options to buy
@ $0.75, valued at
$4.9k
Bought 769,989 options to buy
@ $0.65, valued at
$500.5k
|
|
02/15/2018 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on Cardlytics, Inc.
Txns:
| Converted 771,947 shares
@ $0 Converted 15,045 shares
@ $0 Converted 5,287 shares
@ $0 Converted 7,719 shares
@ $0 Converted 931,174 shares
@ $0 Converted 18,148 shares
@ $0 Converted 6,378 shares
@ $0 Converted 9,311 shares
@ $0 Converted 417,683 shares
@ $0 Converted 8,140 shares
@ $0 Converted 2,861 shares
@ $0 |
|
11/20/2017 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on Arsanis, Inc.
Txns:
| Converted 18,848 shares
@ $0 Converted 367 shares
@ $0 Converted 129 shares
@ $0 Converted 188 shares
@ $0 Converted 243,385 shares
@ $0 Converted 4,743 shares
@ $0 Converted 1,667 shares
@ $0 Converted 2,433 shares
@ $0 Converted 317,376 shares
@ $0 Converted 6,185 shares
@ $0 Converted 2,173 shares
@ $0 |
|
06/29/2016 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on SELECTA BIOSCIENCES INC
Txns:
| Converted 32,207 shares
@ $0 Converted 11,318 shares
@ $0 Converted 16,524 shares
@ $0 Converted 1,652,646 shares
@ $0 Bought 2,821 shares
@ $14, valued at
$39.5k
Bought 991 shares
@ $14, valued at
$13.9k
Bought 1,448 shares
@ $14, valued at
$20.3k
Bought 144,740 shares
@ $14, valued at
$2M
Converted 6,494 convertible preferred
@ $0 Converted 2,282 convertible preferred
@ $0 Converted 3,332 convertible preferred
@ $0 |
|
08/07/2015 |
4
| Polaris Venture Partners V, L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 202 shares
@ $15.0201, valued at
$3k
Sold 71 shares
@ $15.0201, valued at
$1.1k
Sold 104 shares
@ $15.0201, valued at
$1.6k
Sold 10,367 shares
@ $15.0201, valued at
$155.7k
|
|
07/24/2015 |
4
| Polaris Venture Partners V, L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 282 shares
@ $15.0426, valued at
$4.2k
Sold 99 shares
@ $15.0426, valued at
$1.5k
Sold 144 shares
@ $15.0426, valued at
$2.2k
Sold 14,474 shares
@ $15.0426, valued at
$217.7k
Sold 8 shares
@ $15, valued at
$120 Sold 3 shares
@ $15, valued at
$45 Sold 4 shares
@ $15, valued at
$60 Sold 385 shares
@ $15, valued at
$5.8k
|
|
07/22/2015 |
4
| Polaris Venture Partners V, L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 282 shares
@ $16.0522, valued at
$4.5k
Sold 99 shares
@ $16.0522, valued at
$1.6k
Sold 144 shares
@ $16.0522, valued at
$2.3k
Sold 14,474 shares
@ $16.0522, valued at
$232.3k
Sold 282 shares
@ $15.4209, valued at
$4.3k
Sold 99 shares
@ $15.4209, valued at
$1.5k
Sold 144 shares
@ $15.4209, valued at
$2.2k
Sold 14,474 shares
@ $15.4209, valued at
$223.2k
Sold 282 shares
@ $15.2243, valued at
$4.3k
Sold 99 shares
@ $15.2243, valued at
$1.5k
Sold 144 shares
@ $15.2243, valued at
$2.2k
|
|
07/17/2015 |
4
| Polaris Venture Partners V, L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 282 shares
@ $16.1437, valued at
$4.6k
Sold 99 shares
@ $16.1437, valued at
$1.6k
Sold 144 shares
@ $16.1437, valued at
$2.3k
Sold 14,474 shares
@ $16.1437, valued at
$233.7k
Sold 282 shares
@ $16.3316, valued at
$4.6k
Sold 99 shares
@ $16.3316, valued at
$1.6k
Sold 144 shares
@ $16.3316, valued at
$2.4k
Sold 14,474 shares
@ $16.3316, valued at
$236.4k
Sold 282 shares
@ $16.2978, valued at
$4.6k
Sold 99 shares
@ $16.2978, valued at
$1.6k
Sold 144 shares
@ $16.2978, valued at
$2.3k
|
|
07/14/2015 |
4
| Polaris Venture Partners V, L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 282 shares
@ $16.5957, valued at
$4.7k
Sold 99 shares
@ $16.5957, valued at
$1.6k
Sold 144 shares
@ $16.5957, valued at
$2.4k
Sold 14,474 shares
@ $16.5957, valued at
$240.2k
Sold 282 shares
@ $16.5413, valued at
$4.7k
Sold 99 shares
@ $16.5413, valued at
$1.6k
Sold 144 shares
@ $16.5413, valued at
$2.4k
Sold 14,474 shares
@ $16.5413, valued at
$239.4k
|
|
07/10/2015 |
4
| Polaris Venture Partners V, L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 282 shares
@ $15.9949, valued at
$4.5k
Sold 99 shares
@ $15.9949, valued at
$1.6k
Sold 144 shares
@ $15.9949, valued at
$2.3k
Sold 14,474 shares
@ $15.9949, valued at
$231.5k
Sold 282 shares
@ $16.1239, valued at
$4.5k
Sold 99 shares
@ $16.1239, valued at
$1.6k
Sold 144 shares
@ $16.1239, valued at
$2.3k
Sold 14,474 shares
@ $16.1239, valued at
$233.4k
Sold 282 shares
@ $16.6255, valued at
$4.7k
Sold 99 shares
@ $16.6255, valued at
$1.6k
Sold 144 shares
@ $16.6255, valued at
$2.4k
|
|
07/07/2015 |
4
| Polaris Venture Partners V, L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 282 shares
@ $15.5053, valued at
$4.4k
Sold 99 shares
@ $15.5053, valued at
$1.5k
Sold 144 shares
@ $15.5053, valued at
$2.2k
Sold 14,474 shares
@ $15.5053, valued at
$224.4k
Sold 282 shares
@ $15.9807, valued at
$4.5k
Sold 99 shares
@ $15.9807, valued at
$1.6k
Sold 144 shares
@ $15.9807, valued at
$2.3k
Sold 14,474 shares
@ $15.9807, valued at
$231.3k
Sold 282 shares
@ $16.23, valued at
$4.6k
Sold 99 shares
@ $16.23, valued at
$1.6k
Sold 144 shares
@ $16.23, valued at
$2.3k
|
|
07/01/2015 |
4
| Polaris Venture Partners V, L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 282 shares
@ $16.2768, valued at
$4.6k
Sold 99 shares
@ $16.2768, valued at
$1.6k
Sold 144 shares
@ $16.2768, valued at
$2.3k
Sold 14,474 shares
@ $16.2768, valued at
$235.6k
Sold 282 shares
@ $16.2157, valued at
$4.6k
Sold 99 shares
@ $16.2157, valued at
$1.6k
Sold 144 shares
@ $16.2157, valued at
$2.3k
Sold 14,474 shares
@ $16.2157, valued at
$234.7k
Sold 282 shares
@ $15.7728, valued at
$4.4k
Sold 99 shares
@ $15.7728, valued at
$1.6k
Sold 144 shares
@ $15.7728, valued at
$2.3k
|
|
06/26/2015 |
4
| Polaris Venture Partners V, L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 282 shares
@ $17.6129, valued at
$5k
Sold 99 shares
@ $17.6129, valued at
$1.7k
Sold 144 shares
@ $17.6129, valued at
$2.5k
Sold 14,474 shares
@ $17.6129, valued at
$254.9k
Sold 282 shares
@ $16.8531, valued at
$4.8k
Sold 99 shares
@ $16.8531, valued at
$1.7k
Sold 144 shares
@ $16.8531, valued at
$2.4k
Sold 14,474 shares
@ $16.8531, valued at
$243.9k
Sold 282 shares
@ $16.7607, valued at
$4.7k
Sold 99 shares
@ $16.7607, valued at
$1.7k
Sold 144 shares
@ $16.7607, valued at
$2.4k
|
|
06/24/2015 |
4
| Polaris Venture Partners V, L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Sold 282 shares
@ $18.2169, valued at
$5.1k
Sold 99 shares
@ $18.2169, valued at
$1.8k
Sold 144 shares
@ $18.2169, valued at
$2.6k
Sold 14,474 shares
@ $18.2169, valued at
$263.7k
Sold 282 shares
@ $18.1473, valued at
$5.1k
Sold 99 shares
@ $18.1473, valued at
$1.8k
Sold 144 shares
@ $18.1473, valued at
$2.6k
Sold 14,474 shares
@ $18.1473, valued at
$262.7k
|
|
06/19/2015 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 29,004 shares
@ $13.04, valued at
$378.2k
Sold 1,000 shares
@ $13, valued at
$13k
|
|
06/17/2015 |
4
| MCGUIRE TERRANCE (10% Owner) has filed a Form 4 on Pulmatrix, Inc.
Txns:
| Granted 1,179,066 shares
@ $0 Bought 32,059 shares
@ $6.875, valued at
$220.4k
Granted 22,099 shares
@ $0 Bought 601 shares
@ $6.875, valued at
$4.1k
Granted 2,626,762 shares
@ $0 Bought 71,438 shares
@ $6.875, valued at
$491.1k
Granted 18,110 shares
@ $0 Bought 489 shares
@ $6.875, valued at
$3.4k
Granted 26,172 shares
@ $0 Bought 714 shares
@ $6.875, valued at
$4.9k
Granted 51,330 shares
@ $0 |
|
06/17/2015 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 46,000 shares
@ $13.24, valued at
$609k
Sold 10,618 shares
@ $13.01, valued at
$138.1k
|
|
05/14/2015 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on aTYR PHARMA INC
Txns:
| Converted 1,674,825 shares
@ $0 Converted 32,642 shares
@ $0 Converted 11,472 shares
@ $0 Converted 16,748 shares
@ $0 Converted 89,069 shares
@ $0 Converted 1,736 shares
@ $0 Converted 610 shares
@ $0 Converted 890 shares
@ $0 Converted 3,473,763 options to buy
@ $0 Converted 67,704 options to buy
@ $0 Converted 23,796 options to buy
@ $0 |
|
02/04/2015 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Sold 482,469 shares
@ $29.5, valued at
$14.2M
Sold 9,403 shares
@ $29.5, valued at
$277.4k
Sold 3,304 shares
@ $29.5, valued at
$97.5k
Sold 4,824 shares
@ $29.5, valued at
$142.3k
|
|
08/18/2014 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on TREVENA INC
Txns:
| Sold 35,415 shares
@ $6.04, valued at
$213.9k
Sold 690 shares
@ $6.04, valued at
$4.2k
Sold 243 shares
@ $6.04, valued at
$1.5k
Sold 354 shares
@ $6.04, valued at
$2.1k
|
|
08/15/2014 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on TREVENA INC
Txns:
| Sold 5,500 shares
@ $6.12, valued at
$33.7k
Sold 107 shares
@ $6.12, valued at
$654.8 Sold 38 shares
@ $6.12, valued at
$232.6 Sold 55 shares
@ $6.12, valued at
$336.6 |
|
08/15/2014 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 2,905 shares
@ $13, valued at
$37.8k
Sold 6,755 shares
@ $13.01, valued at
$87.9k
|
|
08/14/2014 |
4
| Polaris Venture Partners V, L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.
Txns:
| Converted 44,657 shares
@ $0 Converted 15,695 shares
@ $0 Converted 22,912 shares
@ $0 Converted 2,291,307 shares
@ $0 Converted 128,567 convertible preferred
@ $0 Converted 774,527 convertible preferred
@ $0 Converted 1,053,201 convertible preferred
@ $0 Converted 819,493 convertible preferred
@ $0 Converted 629,852 convertible preferred
@ $0 Converted 631,133 convertible preferred
@ $0 |
|
08/12/2014 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Sold 41,376 shares
@ $13.41, valued at
$554.9k
Sold 1,428 shares
@ $13.24, valued at
$18.9k
Sold 20,990 shares
@ $13.03, valued at
$273.5k
|
|
07/31/2014 |
4
| Polaris Venture Management Co. V, L.L.C. (10% Owner) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Converted 1,525,312 shares
@ $0 Converted 29,728 shares
@ $0 Converted 10,448 shares
@ $0 Converted 15,253 shares
@ $0 Converted 915,981 shares
@ $0 Converted 17,853 shares
@ $0 Converted 6,275 shares
@ $0 Converted 9,159 shares
@ $0 Converted 4,026,825 preferred shares
@ $0 Converted 78,483 preferred shares
@ $0 Converted 27,584 preferred shares
@ $0 |
|
|
|
|